Filing Details
- Accession Number:
- 0000929638-24-003217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 16:04:18
- Reporting Period:
- 2024-09-20
- Accepted Time:
- 2024-09-24 16:04:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1595097 | Corbus Pharmaceuticals Holdings Inc. | CRBP | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1583977 | Cormorant Asset Management, Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No | |
1599214 | Bihua Chen | C/O Cormorant Asset Management, Lp 200 Clarendon Street, 52Nd Floor Boston MA 02116 | No | No | No | No | |
1618442 | Cormorant Global Healthcare Master Fund, Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-09-20 | 45,085 | $17.48 | 2,070,085 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2024-09-20 | 25,943 | $18.36 | 2,096,028 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2024-09-20 | 66,088 | $19.61 | 2,162,116 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2024-09-20 | 139,551 | $20.42 | 2,301,667 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2024-09-20 | 47,564 | $21.47 | 2,349,231 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2024-09-20 | 25,769 | $22.23 | 2,375,000 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $17.00 to $17.95 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the "SEC"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below).
- Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
- Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $18.03 to $18.999 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
- Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $19.00 to $19.998 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
- Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $20.00 to $20.995 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
- Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $21.00 to $21.99 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.
- Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $22.00 to $22.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.